Proper Administration of Lemborexant

Release date: 2026-06-29 17:23:32     Recommended: 7

Proper Administration of Lemborexant

Lemborexant is taken only once each night, and must be taken immediately before you get into bed with the intention of sleeping. Strictly adhere to the dose prescribed by your physician; do not increase or decrease it on your own. The key prerequisite is that you must be able to ensure a continuous 7-hour period remaining in bed after taking the medication; otherwise, you should not take it. For optimal absorption, it is recommended to take it on an empty stomach or with a light snack; if taken after a heavy meal or shortly after eating, the onset of action may be delayed, potentially impairing sleep initiation. Do not take a supplemental dose if you wake up in the middle of the night, and do not take it more than once in a single night. If you occasionally miss a dose, skip that dose and take the next one at the usual time the following night; do not double the dose. Maintain a regular dosing schedule throughout the treatment period, and keep a record of your sleep responses to discuss adjustments with your doctor during follow-up visits.

Contraindications for Lemborexant

The following conditions absolutely preclude the use of lemborexant: (1) a confirmed diagnosis of narcolepsy (i.e., excessive daytime sleepiness and sudden sleep attacks); and (2) known hypersensitivity to any component of this product. Additionally, although not listed as an absolute contraindication in the product labeling, patients with severe hepatic impairment should use it with caution, because the liver is the primary metabolic pathway and may affect drug clearance. For patients with a history of alcohol or substance abuse or dependence, given the potential abuse liability of lemborexant, the physician will weigh risks and benefits and may choose an alternative therapy. Meanwhile, the safety of lemborexant in pregnant and breastfeeding women has not been fully established; it is currently known that lemborexant can pass into human milk, so it is not recommended unless the physician explicitly determines that the benefit outweighs the risk. Women who are planning pregnancy or are already pregnant must inform their doctor before starting the medication.

Dependence and Abuse Potential of Lemborexant

Lemborexant is classified as a Schedule IV controlled substance under U.S. federal law, meaning that while it has recognized medical value, it carries a potential for abuse and dependence. In clinical trials, patients did not exhibit significant withdrawal signs or symptoms upon discontinuation, suggesting a low physiological dependence profile; however, this does not equate to an absence of psychological dependence risk. Patients should use the medication strictly as prescribed and must not increase the dose on their own or transfer it to others. Selling or giving away the medication is illegal and may cause serious harm to others. Individuals with a prior history of alcohol, prescription drug, or street drug abuse or dependence should fully disclose this to their physician before treatment to facilitate risk assessment. To prevent misuse, the medication should be stored in a secure place out of reach of children and used only by the person for whom it was prescribed. If you find that you need progressively higher doses to achieve the same effect, seek medical attention promptly; do not adjust the dose on your own.